According to a recent research analysis by MarkNtel Advisors, the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market is expected to expand at a rate of about 23.6% CAGR from 2021-26. It includes a thorough analysis of the most recent market trends, developments, drivers, restraints, challenges, and opportunities, as well as a projection of the industry’s growth trajectory over the coming years across various segments & geographies.
The research also emphasises key elements that are shown in diagrams, pie charts, tables, graphs, and other visual representations and that will help the market grow in the future. Through this knowledge, market participants will be better able to plan and lay out strategies to increase their visibility, product portfolio, and clientele while generating sizable profits. They will also be able to comprehend the shifting dynamics of the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market. The historical years taken into account in the report are 2016–19, 2020 serves as the baseline year, and the previously mentioned prediction term is 2021–26.
Key Findings from the Market Analysis of Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials
The essential elements influencing the dynamics of the industry are compiled in this analysis, including, among others, developing and high-potential categories and geographies, growth drivers, restraints, opportunities, and difficulties.
Detail-oriented, accurate, and trustworthy information about the most recent developments in the market to assist stakeholders or investors in making wise judgments before making investments.
An in-depth analysis of the top market players in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market, including information on their latest advancements, key business efforts, business strategies, and mergers and acquisitions, among other things.
This study also includes insights into each market sector and region, along with funding estimates made by private companies and governments for the industry’s growth.
market growth accelerator
Improvements in artificial intelligence (AI), 4K imaging, and IoT (Internet of Things) have led to an increase in demand for integrating these cutting-edge technologies in the healthcare sector. AI assists in the delivery of patient-centered care, enhanced diagnostic services, and precise decision-making by spotting defects in existing circumstances and recommending better options in challenging scenarios. Therefore, it is anticipated that the development of the market for drug discovery and clinical trials will be aided by AI technology.
Major Market Growth Challenges –
One of the most prominent concerns during the medication research stage is patient health. Dynamic activities analyse data on the effects of drugs that have been reported and forecast their negative consequences, which may be a significant market restraint. A lack of qualified workers and inadequate datasets for drug research and development are additional important factors that could have an effect on the market’s expansion.
Segmentation of the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market: The segmentation analysis section of the report focuses on the performance of the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market across various segments & geographies, which can help stakeholders plan their investments in order to increase their visibility, product portfolio, and customer base and, in turn, generate sizable revenue in the future.
Market Segmentation: Software, By Component
-Service
Market Segments, Organized by Application
-Data Analysis and Aggregation
Trials in Clinics
Drug Characterization and Design
-Dividing the Biomarker Research Market by Therapeutic Application
-Oncology
Cardiovascular Illness
-Neurological Disorder
-Metabolic Disorder -Respiratory Disorder
Immunologic Conditions
-Irritable Illness
-Others
Market Segmented, By End
-Contract Research Organization -User -Biopharmaceutical Industry (CROs)
-Research Centers and Academic Institutes
Geographically, the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market is expanding across the following continents:
-Europe
-Asia-Pacific
Mideast and Africa
(Note: The rise of the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market in the North American area is attributed to growing awareness of the advantages of incorporating AI in the drug discovery process.)
Competitive Environment:
In-depth data on firm profiles, investments and revenue generated, strategic efforts, regional presence, and production or service capacities, among other factors, have all been analysed under this section. To assist investors in making wise investment selections, all insights into firms have only been collected after carefully examining their position in the industry.
Biotechnology Accutar
-AiCure, LLC -Atomwise Inc. -Ardigen
Cloud Pharmaceuticals Berg LLc
Symphony Innovations, Biovista, Cyclica Inc., GNS Healthcare
